CD72, a negative regulator of B-cell responsiveness

被引:0
作者
Parnes, JR [1 ]
Pan, C [1 ]
机构
[1] Stanford Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol,Sch Med, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of lymphocytes to respond to antigenic or mitogenic stimulation is regulated not only by specific receptor proteins, but also by both positive and negative regulatory proteins that set or fine-tune the threshold for responsiveness. CD72 is one such regulatory protein on B lymphocytes, It is a member of the C-type lectin superfamily and is expressed on the surface of B cells from the pro-B through the mature B-cell stage. Studies with anti-CD72 antibodies have suggested a positive regulatory role for CD72 in B-cell activation. However, the cytoplasmic tail of CD72 contains two potential immunoreceptor tyrosine-based inhibitory motifs, one of which has been shown to recruit the tyrosine phosphatase SHP-1. These features suggest a negative regulatory role for CD72. We have generated CD72-deficient mice to elucidate the physiological role of CD72 in B-lymphocyte development and activation. Our analyses of these mice and their B-cell compartment demonstrate that CD72 is a nonredundant regulator of B-cell development and a negative regulator of B-cell responsiveness.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 50 条
[21]   A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren's syndrome [J].
Shen, Yuqi ;
Ma, Yuhua ;
Xie, Jingyuan ;
Lin, Li ;
Shi, Yifan ;
Li, Xiao ;
Shen, Pingyan ;
Pan, Xiaoxia ;
Ren, Hong .
BMC IMMUNOLOGY, 2020, 21 (01)
[22]   EXPRESSION OF CD5 AND CD72 ON T-CELL AND B-CELL SUBSETS IN RHEUMATOID-ARTHRITIS AND SJOGRENS-SYNDROME [J].
JAMIN, C ;
LAMOUR, A ;
PENNEC, YL ;
HIRN, M ;
LEGOFF, P ;
YOUINOU, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1993, 92 (02) :245-250
[23]   A regulatory role for CD72 expression on B cells and increased soluble CD72 in primary Sjogren’s syndrome [J].
Yuqi Shen ;
Yuhua Ma ;
Jingyuan Xie ;
Li Lin ;
Yifan Shi ;
Xiao Li ;
Pingyan Shen ;
Xiaoxia Pan ;
Hong Ren .
BMC Immunology, 21
[24]   Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis [J].
Zheng, Mingke ;
Xing, Chen ;
Xiao, He ;
Ma, Ning ;
Wang, Xiaoqian ;
Han, Gencheng ;
Chen, Guojiang ;
Hou, Chunmei ;
Shen, Beifen ;
Li, Yan ;
Wang, Renxi .
IMMUNOLOGICAL INVESTIGATIONS, 2014, 43 (07) :705-716
[25]   CD72 ligation regulates defective naive newborn B cell responses [J].
Howard, LM ;
Reen, DJ .
CELLULAR IMMUNOLOGY, 1997, 175 (02) :179-188
[26]   CD72 as a potential new therapeutic target in diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) [J].
Von Euw, Erika ;
Taschereau, Eileen ;
Ou, Da Ming ;
Mead, Monica ;
Larson, Sarah ;
Slamon, Dennis .
CANCER RESEARCH, 2019, 79 (13)
[27]   B-cell co-receptor CD72 is expressed on NK cells and inhibits IFN-γ production but not cytotoxicity [J].
Alcon, Valeria L. ;
Luther, Claudia ;
Balce, Dale ;
Takei, Fumio .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (03) :826-832
[28]   Selective response of CD5+ B cell malignancies to activation of the CD72 antigen [J].
Planken, EV ;
Van de Velde, H ;
Falkenburg, JHF ;
Thielemans, K ;
Willemze, R ;
Kluin-Nelemans, JC .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 87 (01) :42-49
[29]   The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1 [J].
Wu, YJ ;
Nadler, MJS ;
Brennan, LA ;
Gish, GD ;
Timms, JF ;
Fusaki, N ;
Jongstra-Bilen, J ;
Tada, N ;
Pawson, T ;
Wither, J ;
Neel, BG ;
Hozumi, N .
CURRENT BIOLOGY, 1998, 8 (18) :1009-1017
[30]   Selective over-expression of B-cell regulatory molecule CD72 in primary Sjogren's syndrome. [J].
Smith, AJF ;
Gordon, TP ;
McArdle, P .
ARTHRITIS AND RHEUMATISM, 2002, 46 (09) :S359-S359